Moderna
MRNA
#1630
Rank
S$13.06 B
Marketcap
$33.79
Share price
-2.41%
Change (1 day)
-75.50%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Moderna (MRNA) - Total assets

Total assets on the balance sheet as of December 2024 : S$19.02 Billion

According to Moderna 's latest financial reports the company's total assets are S$19.02 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Moderna - Total assets on balance sheet (from 2017 to 2024)

Total assets by year

Year Total assets Change
2024-12-31S$19.22 B-21.01%
2023-12-31S$24.33 B-29.8%
2022-12-31S$34.66 B3.94%
2021-12-31S$33.35 B243.59%
2020-12-31S$9.70 B352.97%
2019-12-31S$2.14 B-20.06%
2018-12-31S$2.68 B84.8%
2017-12-31S$1.45 B-29.28%
2016-12-31S$2.05 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
S$0.11 B-99.40%๐Ÿ‡บ๐Ÿ‡ธ USA
S$157.56 B 728.07%๐Ÿ‡บ๐Ÿ‡ธ USA
S$9.99 M-99.95%๐Ÿ‡บ๐Ÿ‡ธ USA
S$5.70 B-70.02%๐Ÿ‡บ๐Ÿ‡ธ USA
S$137.57 B 623.00%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
S$1.36 B-92.83%๐Ÿ‡บ๐Ÿ‡ธ USA
S$242.32 B 1,173.54%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA